Dong Lyu
Direktor/Vorstandsmitglied bei GENOR BIOPHARMA HOLDINGS LIMITED
Aktive Positionen von Dong Lyu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
GENOR BIOPHARMA HOLDINGS LIMITED | Direktor/Vorstandsmitglied | 02.11.2021 | - |
LUYE PHARMA GROUP LTD. | Direktor/Vorstandsmitglied | 06.12.2023 | - |
Zhuhai Hillhouse Investment Management Holding Co. Ltd. | Corporate Officer/Principal | 30.09.2020 | - |
Zhuhai Gao Ling Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01.09.2020 | - |
Karriereverlauf von Dong Lyu
Ehemalige bekannte Positionen von Dong Lyu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Direktor/Vorstandsmitglied | 30.11.2020 | 31.08.2023 |
CLOVER BIOPHARMACEUTICALS, LTD. | Direktor/Vorstandsmitglied | 16.03.2021 | 28.10.2022 |
KEYMED BIOSCIENCES INC. | Direktor/Vorstandsmitglied | 03.03.2021 | 29.03.2022 |
Pag Growth Zhuhai Holding Investment Management Co. Ltd. | Corporate Officer/Principal | 01.09.2016 | 01.09.2020 |
Shanghai Panxin Equity Investment Management Co. Ltd. | Corporate Officer/Principal | 01.07.2011 | 01.07.2016 |
░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Ausbildung von Dong Lyu
Beijing Medical University | Undergraduate Degree |
China Pharmaceutical University | Doctorate Degree |
Peking University | Graduate Degree |
Statistik
International
China | 9 |
Cayman Islands | 4 |
Hong Kong | 2 |
Operativ
Director/Board Member | 6 |
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
KEYMED BIOSCIENCES INC. | Health Technology |
JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
GENOR BIOPHARMA HOLDINGS LIMITED | Health Technology |
LUYE PHARMA GROUP LTD. | Health Technology |
Private Unternehmen | 5 |
---|---|
Shanghai Panxin Equity Investment Management Co. Ltd. | |
Pag Growth Zhuhai Holding Investment Management Co. Ltd. | |
Zhuhai Hillhouse Investment Management Holding Co. Ltd. | |
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
Zhuhai Gao Ling Equity Investment Management Co. Ltd. |